The study of the risk factors of airway obstruction after sleep induced by drugs

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042083

Enrollment

Unknown

Registered

2021-01-13

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway obstruction

Interventions

Midazolam group:Midazolam was given intravenously

The esketamine group:Esketamine was given intravenously

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged >= 18 years and ASA <= II level.

Exclusion criteria

Exclusion criteria: Airway foreign body, airway tumor, airway inflammation, airway injury, myasthenia gravis, epilepsy and other psychiatric diseases.

Design outcomes

Primary

Measure	Time frame
Grade of airway obstruction;	—

Secondary

Measure	Time frame
Frequency of apnea;Low ventilation rate;oxygen saturation;	—

Countries

China

Contacts

Public ContactXingxing Guo

Guangdong Provincial People's Hospital Zhuhai Hospital (Zhuhai Golden Bay Center Hospital)

821517760@qq.com+86 15217173001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026